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CASE REPORT
MASSIVE NECROTIZING PANCREATITIS IN AN
IMMUNOSUPPRESSED RENAL TRANSPLANT
RECIPIENT (SUCCESSFUL THERAPY)
JOEL W. SLATON, JOHN M. HOWARD and STEVEN H. SELMAN
Department of Urology and Department of Surgery, Medical College of Ohio and
The Toledo Hospital, Toledo, Ohio, USA
(Received 31 August 1992)
Severe pancreatitis may be associated with massive necrosis of the pancreas and/or retroperitoneal
adipose tissue. Toxicity results from the dead tissue and secondary infection. A 45 year old patient,
while fully immunosuppressed, developed this complication following cadaveric renal transplantation.
He survived continued immunosuppression, 16 operative debridements of the retroperitoneum, and
maintained a functioning renal transplant.
In view of the previously reported high mortality rates from mild pancreatitis after transplantation,
the current experience warrants further evaluation of the open method of treatment.
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INTRODUCTION
Within the past decade, mortality rates from massive pancreatic and peripancreatic
necrosis have been reported to be quite high as high as 50--100% in earlier
series. The mortality rate today is falling, although many patients develop a
complicated and near fatal course. Most of the necrotic retroperitoneal tissue is
now recognized as being necrotic adipose tissue, although portions of the pancreas
may sometimes undergo necrosis’2. The role of infection has been central to most
discussions of management.
Acute pancreatitis is a well known complication of renal transplantation. The
resultant mortality rates have been extremely high, even with pancreatitis of a mild
or moderate degree of severity3-5.
As an indication of progress in the management of such patients, the following
report reflects the advances currently underway. The patient developed acute
pancreatitis with massive retroperitoneal necrosis while immunosuppressed after
renal transplantation, remaining immunosuppressed, and was discharged from the
hospital with his transplant kidney still functioning.
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CASE REPORT
A 45-year-old white male with end-stage glomerulonephritis underwent a cadaveric
renal transplantation on January 15, 1989. Immunosuppression in the immediate
postoperative period included prednisone 200 mg daily, subsequently tapered to 30
mg per day on postoperative day 19. Cyclosporine A, 14 mg/kg, was also
administered. On the second postoperative day, the patient unexpectedly became
oliguric. A renal ultrasound showed no evidence of obstruction, and a renal scan
revealed unobstructed blood flow to the transplanted kidney. The overall picture
was consistent with acute tubular necrosis. Consequently, the daily cyclosporine
dosage was reduced to 5 mg/kg and azathioprine, 1.5 mg/kg daily, was added.
Hemodialysis was begun the second postoperative day; the patient’s serum calcium
had declined to 5.8 mg/dl. Hypocalcemia persisted, falling to 4.3 mg/dl before being
reversed by repeated intravenous infusions of calcium gluconate. The patient’s
serum calcium level stabilized by the seventh postoperative day at 7.2 mg/dl.
Gross hematuria developed on the seventh postoperative day. Significant labora-
tory findings included a prothrombin time of 28.3 seconds, a partial thromboplastin
time of 41.9 seconds, a platelet count of 179,000, and a normal fibrinogen level.
Azathioprine was discontinued and the patient was also treated with a transfusion
of fresh frozen plasma. Oliguria had resolved by the eighth postoperative day.
On the 11th postoperative day, the patient complained of nausea and abdominal
pain. At the same time, his white blood cell count increased to 20 x 103/mm.
Serum amylase and lipase levels, measured for the first time, were normal. A
voiding cystogram showed no evidence of urinary extravasation. An abdominal CT
scan revealed a markedly enlarged pancreas with an extensive peripancreatic fluid
collection. The patient was diagnosed as having acute pancreatitis. Initial treatment
consisted of nasogastric suction and total parenteral nutrition. On the 17th
postoperative day, the patient developed spiking temperatures to 39.2 C. Blood
cultures grew pseudomonas aeruginosa, for which the patient was started on
Tobramycin and Ceftazidime.
On the 17th postoperative day, a repeat CT revealed progression of the
peripancreatic necrosis with extension into the fat planes and soft tissues of the
retroperitoneum (Figures la and lb). The renal function remained stable (creati-
nine 1.7 mg/dl) on an immunosuppressive regimen of intravenous cyclosporine (5.5
mg/kg) and methylprednisolone (35 mg/day). A Hickman central venous catheter
was inserted on the 24th postoperative day to permit prolonged parenteral
nutrition. The transplant incision continued to drain purulent fluid. On postopera-
tive day 35, severe diarrhea developed secondary to C1. difficile. Tobramycin and
Ceftazidime were discontinued, and metronidazole was started.
On the 38th postoperative day, spiking fevers recurred. Blood cultures demon-
strated Pseudomonas. A repeat CT scan showed further extension of the inflamma-
tory process into the retroperitoneum with the loss of the normal anatomical
markings of the pancreas. Two fluid collections were identified, one 6.5 cm
diameter and another 7.5 cm diameter were in or adjacent to the head and body,
respectively. A CT-directed aspiration of peripancreatic fluid was performed.
Twenty millimeters of thick, chocolate-colored fluid was obtained. Cultures of this
material were positive for Pseudomonas.
The patient continued to manifest fever and leukocytosis. Exploration via a
bilateral subcostal incision was performed on the 39th post-transplant day andMASSIVE PANCREATITIS 159
Figure la CT on 17th post-transplant day showing large retrogastric area of peripancreatic necrosis.
Note gas bubbles in the necrotic debris.
Figure lb CT of the same date revealing extension of the necrotic mass into the mesentery of the
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consisted of extensive peripancreatic necrosectomy (Figure 2) and open drainage
the peripancreatic abscess (Figure 3). Through a separate incision, a feeding
jejunostomy tube was inserted. The necrosectomy wound was packed open in
anticipation of further debridement. Tobramycin and Ceftazadime were restarted.
In the subsequent 51 days, a total of 15 additional intraoperative dressing changes
and necrosectomies were performed under general anesthesia. At this point, twice-
a-day bedside irrigations and dressing changes were begun. On April 21, 1989, the
95th post-transplant day, a repeat CT scan revealed no further fluid collections.
Tobramycin and Ceftazidime had been discontinued two weeks after the initial
drainage procedure. During the six weeks of intraoperative dressing changes, the
patient was treated twice for staphylococcus epidermidis bacteremia with seven day
courses of Vancomycin. Nutrition was maintained primarily through the jejunos-
tomy, supplemented as necessary by parenteral nutrition.
Therefore, the patient continued to experience low grade fevers and intermittent
drainage from the transplant wound. This was believed to represent egress of
residual retroperitoneal tissue. His fever eventually resolved and by the 130th
postoperative day, the pancreatic necrosectomy wound was clean and granulating.
The transplant wound continued to drain a moderate amount of purulent material.
The renal allograft continued to function well maintaining a serum creatinine of 1.1
mg/dl. Twelve months after transplantation, the kidney failed. Biopsy revealed
advanced glomerulonephritis in the transplanted kidney. Chronic hemodialysis was
Figure 2 Necrotic retroperitoneal, peripancreatic adipose tissue debrided on the 39th post-transplant
day. This was the initial debridement.MASSIVE PANCREATITIS 161
Figure 3 The appearance of the open bilateral subcostal incision on the 23rd day after the initial
debridement. Healing has been impaired. Through the sutured incision, inferior to the open wound, a
jejunostomy had been performed for feeding. The small jejunostomy tube can be seen exiting the left
flank.162 J.W. SLATON ET AL.
resumed. Eighteen months after onset of the pancreatitis, ERCP revealed normal
pancreatic and common bile ducts. His pancreatic endocrine and exocrine functions
remain clinically stable three and a half years after the attack of pancreatitis.
DISCUSSION
Acute pancreatitis following renal transplantation was first described by Starzl in
19646‘7 Since then, numerous reports have appeared. The incidence of acute
pancreatitis following renal transplantation ranges from 2% to 7% 8. A number of
contributing etiological factors have been proposed in the renal transplant patient:
surgical trauma, corticosteroids (especially during pulse therapy for rejection),
chronic renal failure with its associated hyperparathyroidism, autoimmune disease,
and viral infections5’9’. Azathioprine has long been considered a major causative
agent of pancreatitis in renal transplant recipientsl’2; however, a recent study by
Frick, et al., disputes this assertion13’14.
Cyclosporine is widely used as the primary immunosuppressive agent in both
renal and pancreatic transplants. Controversy exists concerning the role cyclospor-
r
15 ine plays as a causative factor in the pathogenesis of pancreatts; Yoshmu a has
shown that cyclosporine suppresses both the endocrine and exocrine functions in
the pancreas. The same study reports that there was a significantly higher incidence
of pancreatitis in those recipients treated with a cyclosporine and prednisone
immunosuppressive regimen when compared to an azathioprine and prednisone
regimen. In contrast, another recent study has shown no statistical difference
between the incidence of acute pancreatitis in renal allograft recipients receiving
either azathioprine or cyclosporine1.
Our patient developed massive retroperitoneal necrosis around the pancreas,
typical of the severest form of acute pancreatitis. The fact that most of the necrotic
tissue is retroperitoneal adipose tissue rather than pancreas, per se, had been
previously demonstrated in this department. An anatomically well preserved
pancreatic duct may often be demonstrated following recovery of the patient 1.
The diagnosis of acute pancreatitis was not made initially although the hemody-
namic instability and acute renal insufficiency and unusually low serum calcium
levels should have provided an adequate alert. Secondary infection of the peripan-
creatic necrosis evolved early. The risk of pancreatic abscess formation is known to
be higher in the immunocompromised renal transplant recipient. Thus, our patient
combined the most life-threatening aspects of acute pancreatitis; extensive peripan-
creatic necrosis and early secondary infection.
Earlier reviews by Johnson and Nabseth (1970)3, Fernandez and Rosenberg
(1976)4, and Burnstein, et al. (1982)5, reported mortality rates from acute pancrea-
titis in renal transplant recipients of 50%, 70%, and 70%, respectively. Few
authors, except Burnstein and Corrodi have distinguished between the more
frequent, relatively benign interstitial edema of the pancreas (mortality < 10%)
and the more malignant necrotizing pancreatitis represented by our patient. Our
review of recent case reports reveals that among those deaths of renal transplant
recipients that were attributed to acute pancreatitis greater than 88% (24 of 27) of
the deaths were due to the necrotizing form as diagnosed by CT scan, exploratory
laparotomy or postmortem. The other 12% died of the less malignant interstitialMASSIVE PANCREATITIS 163
disease and/or pancreatic pseudocysts. Ten of 27 cases of necrotizing pancreatitis
were undiagnosed until found at autopsy3-5’8’1’15-21.
Important to our patient’s survival was the thorough initial debridement of the
retroperitoneum, the open packing of the large bilateral subcostal incision, and the
primary establishment of a jejunal feeding tube via a separate abdominal incision.
Although Beger
22 has reported significant progress in the treatment of acute
peripancreatic necrosis by debridement and catheter irrigation, we believe that in
the immunosuppressed patient, the wide open drainage may have proven
lifesaving23.
SUMMARY
Necrotizing pancreatitis is a rare but life-threatening complication in renal trans-
plantation. It can be detected by serial clinical examinations, serum amylase or
lipase measurements, and by CT or ultrasound scans. As a complication of renal
transplantation, it has led to very high mortality rates (50-100%). The initial
treatment today is supportive but necrosectomy and open drainage may be needed
when the patient’s condition fails to improve. Sixteen necrosectomies with open
drainage and irrigation were required in our patient. The combination of massive
peripancreatic necrosis with immunosuppression creates a major surgical chal-
lenge. This experience indicates that survival of the patient with maintenance of
function of the allografted kidney is a realistic goal.
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